IL1B and breast cancer: Furthermore, scratch assay and matrigel-coated/uncoated transwell assay showed that these IL-1B-overexpressing human breast cancer cell lines and IL-1B-overexpressing mouse triple negative breast cancer cells (E0771-IL-1B+) exhibited enhanced migratory and invasive capabilities, compared with corresponding wildtype cells [4], [5], [7].